Citryll moves to new premises at Pivot Park in Oss, The Netherlands
Oss, The Netherlands, October 21, 2019 — Citryll announced today that it has occupied new office and lab space at the Pivot Park in Oss the Netherlands.
“Pivot Park is located at the former Merck R&D sites, the birthplace of Keytruda among some of the approved medicines. Pivot Park houses promising product development companies and valuable pharmaceutical service organizations, forming an attractive ecosystem for drug discovery and drug development” says CEO Helmuth van Es.
“Citryll’s lead product CIT-013 interferes with the formation, function and clearance of neutrophil extracellular traps (NETs). Increasingly NETs are shown to play important roles in different human pathologies including for example organ damage, autoimmune diseases, wound healing and cancer metastasis. Pivot Park is an excellent environment for Citryll to further investigate CIT-013’s mechanism of action, as well as to develop all bioanalytical assays needed for CMC and clinical development”, says CSO Renato Chirivi.
About Citryll
Citryll BV is a private pharmaceutical company based in Oss, the Netherlands that is dedicated to the development and commercialization of therapeutics that target NETosis and NETs. Citryll was founded by ModiQuest B.V., originator of the tACPA patents, Helmuth van Es, CEO Citryll (co-founder of Audion Therapeutics, Galapagos, Antabio and Effecta Pharma), and Renato Chirivi, CSO Citryll and co-inventor of tACPA antibodies, (
About Pivot Park
Pivot Park is Europe’s most exciting campus for biopharmaceutical innovation and discovery, based in Oss, the Netherlands. The campus offers lab and office space of any size with access to high-quality pharmaceutical R&D facilities, has a lively pharma based knowledge community and provides entrepreneurial support for companies to excel, accelerate and grow. Among the 60 start-ups and scale-ups are also two GMP-qualified pilot plants (gram-to-kilogram and fill-and-finish) and an ultra-High Throughput Screening Centre for the acceleration of your early drug discovery. On-site analytical support (e.g. NMR and LCMS) and a well-equipped Open Access Laboratory make investments in own equipment less of a challenge. Situated at the homeland of the Dutch Pharmaceutical industry, Pivot Park is perfectly placed to win talent, with space for growth and countryside to enjoy.